← Back
$NAUT All transactions

Nautilus Biotechnology, Inc.

▲ BUY
6 / 10

Conviction

$ Value

$11K

Shares

15,000

Price

$1

Filed

Jun 2

Why this score? (6/10)
  • Open market buy (+3)
  • C-suite insider (+2)
  • Not a 10b5-1 plan (+1)

Insider

Name

Mowry Anna

Title

CFO and Treasurer

CIK

0001856938

Roles

Officer

Transaction Details

Transaction Date

2025-05-29

Code

P

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

83,000

Footnotes

Represents the weighted average share price of an aggregate total of 15,000 shares purchased in the price range of $0.7662 to $0.7489 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares purchased at each separate price. | Includes the following shares of Common Stock acquired through the Issuer's 2021 Employee Stock Purchase Plan: (i) 1,250 shares on December 1, 2022; (ii) 1,250 shares on June 1, 2023; (iii) 1,250 shares on December 1, 2023; (iv) 2,500 shares on May 31, 2024; (v) 2,500 shares on November 29, 2024; and (vi) 2,500 shares on May 30, 2025.

Filing Info

Accession No.

0001808805-25-000051

Form Type

4

Issuer CIK

0001808805

Mowry Anna's History

Date Ticker Type Value
2025-05-29 NAUT $11K

Other Insiders at NAUT (90d)

No other insider activity at this issuer in the last 90 days.